AKT1 and hepatocellular carcinoma: Based on the above analysis results, we proposed a HSALNT0171251/HSALNT0103092/HSALNT0167051-hsa-miR-4443-AKT1 ceRNA network that can respond to baicalin treatment and hinder HCC tumorigenesis (Figure 11).